Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,515
Award facts
- Contract value 100% obligated
- $27,514.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,514.68 by the Defense Logistics Agency on December 18, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by December 19, 2025, with performance taking place at the contractor's Conshohocken facility. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order aligns with the Defense Logistics Agency's Medical Supply Chain operations, which procure critical pharmaceutical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions, making it part of the specialized pharmaceutical portfolio that AmerisourceBergen routinely supplies to military and veteran healthcare networks. The rapid completion timeline of one day reflects the urgent nature of this medical supply delivery, consistent with the dynamic inventory management requirements of federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9Q61?
SPE2DR26F9Q61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9Q61 worth?
The government has obligated $27,515 on SPE2DR26F9Q61.
Is contract SPE2DR26F9Q61 an order under another contract?
Yes. SPE2DR26F9Q61 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Q61 competed?
The extent of competition for SPE2DR26F9Q61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award